Genome-wide polygenic risk scores predict risk of glioma and molecular subtypes.
Saved in:
| Title: | Genome-wide polygenic risk scores predict risk of glioma and molecular subtypes. |
|---|---|
| Authors: | Nakase T; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA., Guerra GA; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Ostrom QT; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina, USA., Ge T; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Psychiatry, Center for Precision Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Melin BS; Department of Diagnostics and Intervention, Oncology Umeå University, Umeå, Sweden., Wrensch M; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Wiencke JK; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Eckel-Passow JE; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA., Bondy ML; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA., Francis SS; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.; Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA., Kachuri L; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA. |
| Corporate Authors: | Glioma International Case-Control Study (GICC) |
| Source: | Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1933-1944. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!